Clinical Trials Directory

Trials / Unknown

UnknownNCT02921152

Bone Marrow Micrometastases in Patients With Early Stage Breast Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Acibadem University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Operable early stage breast cancer patients staged according to NCCN guidelines are subjected to bone marrow aspiration/trephine biopsy at the time of the definitive operation under general anesthesia. The specimen will be fixated in neutral tamponaded formalin and the sections will be examined by H\&E and cytokeratin immunohistochemically. If disseminated tumor cells are identified ER (estrogen receptor), PR (progesterone receptor), HER2/neu will be studied. Disseminated tumor cells will be recorded quantitively and semiquantitatively. Results of the pilot study will be evaluated as observational study.

Conditions

Interventions

TypeNameDescription
PROCEDUREbone marrow aspiration /trephine biopsy

Timeline

Start date
2016-04-01
Primary completion
2018-04-01
Completion
2021-04-01
First posted
2016-10-03
Last updated
2016-10-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02921152. Inclusion in this directory is not an endorsement.

Bone Marrow Micrometastases in Patients With Early Stage Breast Cancer (NCT02921152) · Clinical Trials Directory